Literature DB >> 18367441

Antipsychotic-induced oxidative stress in rat brain.

Márcio R Martins1, Fabrícia C Petronilho, Karin M Gomes, Felipe Dal-Pizzol, Emilio L Streck, João Quevedo.   

Abstract

Typical and atypical antipsychotic drugs have been shown to have different clinical and behavioral profiles. Haloperidol (HAL) is a typical neuroleptic that acts primarily as a D(2) dopamine receptor antagonist. It has been proposed that reactive oxygen species play a causative role in neurotoxic effects induced by HAL. We evaluated oxidative damage in rat brain induced by chronic (28 days) HAL, clozapine (CLO), olanzapine (OLZ) or aripiprazole (ARI) administration. Adult male Wistar rats received daily injections of HAL (1.5 mg/kg), CLO (25 mg/kg), OLZ (2.5, 5 or 10 mg/kg) or ARI (2, 10 or 20 mg/kg); control animals received vehicle (Tween 1% solution). Thiobarbituric acid reactive substances (TBARS) and protein carbonylation were measured in the prefrontal cortex, hippocampus, striatum and cerebral cortex. The results showed that TBARS were increased in the striatum after HAL treatment. On the other hand, TBARS were diminished in the prefrontal cortex by OLZ and ARI. Our results also showed that all drugs tested in this work decreased TBARS levels in the cerebral cortex. In hippocampus, TBARS levels were not altered by any drug. Protein carbonyl content after HAL and CLO treatment was increased in the hippocampus. Moreover, OLZ and ARI did not alter protein carbonyl content when compared to control group. ARI chronic administration (20 mg/kg) also increased mitochondrial superoxide in the prefrontal cortex and striatum. ARI did not alter mitochondrial superoxide in the hippocampus and cerebral cortex. Moreover, HAL, OLZ and CLO did not cause significant alterations in mitochondrial superoxide in rat brain. Our findings demonstrate that OLZ and ARI do not induce oxidative damage in rat brain as observed after HAL and CLO treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18367441     DOI: 10.1007/bf03033368

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  47 in total

1.  Increased indices of free radical activity in the cerebrospinal fluid of patients with tardive dyskinesia.

Authors:  J B Lohr; R Kuczenski; H S Bracha; M Moir; D V Jeste
Journal:  Biol Psychiatry       Date:  1990-09-15       Impact factor: 13.382

Review 2.  Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia.

Authors:  A Y Deutch; B Moghaddam; R B Innis; J H Krystal; G K Aghajanian; B S Bunney; D S Charney
Journal:  Schizophr Res       Date:  1991 Mar-Apr       Impact factor: 4.939

3.  Vitamin E in the treatment of tardive dyskinesia: the possible involvement of free radical mechanisms.

Authors:  J B Lohr; J L Cadet; M A Lohr; L Larson; E Wasli; L Wade; R Hylton; C Vidoni; D V Jeste; R J Wyatt
Journal:  Schizophr Bull       Date:  1988       Impact factor: 9.306

Review 4.  Possible involvement of free radicals in neuroleptic-induced movement disorders. Evidence from treatment of tardive dyskinesia with vitamin E.

Authors:  J L Cadet; J B Lohr
Journal:  Ann N Y Acad Sci       Date:  1989       Impact factor: 5.691

5.  D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics.

Authors:  L Farde; F A Wiesel; A L Nordström; G Sedvall
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 6.  Free radical pathology and antioxidant defense in schizophrenia: a review.

Authors:  S P Mahadik; S Mukherjee
Journal:  Schizophr Res       Date:  1996-03       Impact factor: 4.939

Review 7.  Conventional antipsychotic medications for schizophrenia.

Authors:  L B Dixon; A F Lehman; J Levine
Journal:  Schizophr Bull       Date:  1995       Impact factor: 9.306

8.  The effect of chronic treatment with typical and atypical antipsychotics on working memory and jaw movements in three- and eighteen-month-old rats.

Authors:  Helen Rosengarten; David Quartermain
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2002-10       Impact factor: 5.067

9.  Chronic antipsychotic treatment selectively alters nerve growth factor and neuropeptide Y immunoreactivity and the distribution of choline acetyl transferase in rat brain regions.

Authors:  Francesco Angelucci; Luigi Aloe; Susanne H. M. Gruber; Marco Fiore; Aleksander A. Mathé
Journal:  Int J Neuropsychopharmacol       Date:  2000-03       Impact factor: 5.176

10.  An integrated analysis of acute treatment-emergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: comparisons with placebo, haloperidol, risperidone, or clozapine.

Authors:  Christopher D Carlson; Patrizia A Cavazzoni; Paul H Berg; Hank Wei; Charles M Beasley; John M Kane
Journal:  J Clin Psychiatry       Date:  2003-08       Impact factor: 4.384

View more
  25 in total

Review 1.  Medication-Induced Tardive Dyskinesia: A Review and Update.

Authors:  Elyse M Cornett; Matthew Novitch; Alan David Kaye; Vijay Kata; Adam M Kaye
Journal:  Ochsner J       Date:  2017

2.  Ketamine-induced behavioural and brain oxidative changes in mice: an assessment of possible beneficial effects of zinc as mono- or adjunct therapy.

Authors:  Olakunle James Onaolapo; Olayemi Quyyom Ademakinwa; Temitayo Opeyemi Olalekan; Adejoke Yetunde Onaolapo
Journal:  Psychopharmacology (Berl)       Date:  2017-06-14       Impact factor: 4.530

Review 3.  Tardive Dyskinesia: Treatment Update.

Authors:  Divya Arya; Tarannum Khan; Adam J Margolius; Hubert H Fernandez
Journal:  Curr Neurol Neurosci Rep       Date:  2019-08-16       Impact factor: 5.081

4.  Effect fingerprints of antipsychotic drugs on neural networks in vitro.

Authors:  Philipp Görtz; Uwe Henning; Stephan Theiss; Christian Lange-Asschenfeldt
Journal:  J Neural Transm (Vienna)       Date:  2019-07-18       Impact factor: 3.575

Review 5.  [Oxidative stress in bipolar affective disorder].

Authors:  E Z Reininghaus; S Zelzer; B Reininghaus; N Lackner; A Birner; S A Bengesser; F T Fellendorf; H-P Kapfhammer; H Mangge
Journal:  Nervenarzt       Date:  2014-09       Impact factor: 1.214

6.  Acute and chronic treatment with quetiapine induces antidepressant-like behavior and exerts antioxidant effects in the rat brain.

Authors:  Zuleide M Ignácio; Gislaine Z Réus; Helena M Abelaira; Airam B de Moura; Thays G de Souza; Danyela Matos; Mariana P Goldim; Khiany Mathias; Leandro Garbossa; Fabricia Petronilho; João Quevedo
Journal:  Metab Brain Dis       Date:  2017-05-06       Impact factor: 3.584

7.  Neurobehavioral and genotoxic parameters of antipsychotic agent aripiprazole in mice.

Authors:  Jaqueline Nascimento Picada; Bruna de Jesus Neto Dos Santos; Franciele Celso; Jéssica Dias Monteiro; Kelly Morais Da Rosa; Leandro Rosa Camacho; Luciana Rodrigues Vieira; Taís Madelon Freitas; Tatiana Grasiela Da Silva; Viviane Minuzzo Pontes; Patrícia Pereira
Journal:  Acta Pharmacol Sin       Date:  2011-08-15       Impact factor: 6.150

8.  Antipsychotic induced alteration of growth and proteome of rat neural stem cells.

Authors:  Eakhlas Uddin Ahmed; Selina Ahmed; Wataru Ukai; Izuru Matsumoto; Andrew Kemp; Iain S McGregor; Mohammed Abul Kashem
Journal:  Neurochem Res       Date:  2012-04-18       Impact factor: 3.996

9.  Effect of in utero exposure to the atypical anti-psychotic risperidone on histopathological features of the rat placenta.

Authors:  K P Singh; Manoj K Singh; Shrikant Gautam
Journal:  Int J Exp Pathol       Date:  2016-06-03       Impact factor: 1.925

Review 10.  Bipolar disorder and mechanisms of action of mood stabilizers.

Authors:  Stanley I Rapoport; Mireille Basselin; Hyung-Wook Kim; Jagadeesh S Rao
Journal:  Brain Res Rev       Date:  2009-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.